Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 10/20 | 0.59 |
| ▸ | MEN1 | O00255 | 5/20 | 0.59 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.59 |
| ▸ | POLB | P06746 | 4/20 | 0.59 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.59 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.59 |
| ▸ | ALDH1A1 | P00352 | 10/20 | 0.58 |
| ▸ | KDM4E | B2RXH2 | 6/20 | 0.58 |
| ▸ | GAA | P10253 | 4/20 | 0.58 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.58 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.58 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.58 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.58 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.58 |
| ▸ | APAF1 | O14727 | 1/20 | 0.55 |
| ▸ | HK1 | P19367 | 1/20 | 0.55 |
| ▸ | DNMT1 | P26358 | 1/20 | 0.55 |
| ▸ | CASP3 | P42574 | 1/20 | 0.55 |
| ▸ | SENP8 | Q96LD8 | 1/20 | 0.55 |
| ▸ | SENP7 | Q9BQF6 | 1/20 | 0.55 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30460431 | 1.00 | MAPT (0.59) | MAPTMEN1KMT2APOLBL3MBTL1 | |
| SCHEMBL15189023 | 0.89 | MAPT (0.59) | MAPTMEN1KMT2APOLBL3MBTL1 | |
| SCHEMBL126109 | 0.84 | MAPT (0.57) | MAPTMEN1KMT2APOLBL3MBTL1 | |
| SCHEMBL718255 | 0.82 | MAPT (0.74) | MAPTMEN1KMT2APOLBL3MBTL1 | |
| SCHEMBL31692976 | 0.82 | MAPT (0.44) | MAPTMEN1KMT2APOLBL3MBTL1 | |
| SCHEMBL20739004 | 0.81 | MAPT (0.55) | MAPTMEN1KMT2APOLBL3MBTL1 | |
| SCHEMBL20722838 | 0.81 | MAPT (0.62) | MAPTMEN1KMT2APOLBL3MBTL1 | |
| SCHEMBL20723034 | 0.81 | MAPT (0.62) | MAPTMEN1KMT2APOLBL3MBTL1 | |
| Ammonia Solution, Strong SCHEMBL11877252 | 0.79 | MAPT (0.52) | MAPTMEN1KMT2APOLBL3MBTL1 | |
| SCHEMBL14070022 | 0.78 | LMNA (0.64) | MAPTMEN1KMT2AL3MBTL1ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 745 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118931906-A | 10-23DNAzyme capable of controlling light-operated bioorthogonal regulation and preparation method and application thereof | 兰州交通大学 | 2024-11-12 | — | — | CN | claimed |
| CN-118852032-A | Alpha, beta-unsaturated ketone derivative, preparation method and application thereof | 赣南医科大学 | 2024-10-29 | — | — | CN | claimed |
| CN-112920113-A | Beta amyloid-targeted fluorescent probe, preparation method thereof and application thereof in Alzheimer's disease | 华南理工大学 | 2021-06-08 | — | — | CN | claimed |
| CN-110003031-B | Amphiphilic molecule containing o-nitrobenzyl ester photodegradation group and synthetic method thereof | 大连理工大学 | 2020-06-02 | — | — | CN | claimed |
| CN-110003031-A | Amphiphilic molecule containing o-nitrobenzyl ester photodegradation group and synthetic method thereof | 大连理工大学 | 2019-07-12 | — | — | CN | claimed |
| EP-2358343-B1 | METHOD FOR DECOLOURING KERATINOUS FIBRES | HENKEL AG & CO KGAA (DE) | 2016-10-19 | — | — | EP | claimed |
| US-8268015-B2 | Method for decolorizing keratin-containing fibers | HENKEL AG & CO. KGAA (DE) | 2012-09-18 | — | — | US | claimed |
| EP-1778176-B1 | COMPOSITION FOR COLOURING KERATIN-CONTAINING FIBRES | HENKEL AG & CO KGAA (DE) | 2012-07-25 | — | — | EP | claimed |
| US-20110247644-A1 | Method for Decolorizing Keratin-Containing Fibers | HENKEL AG & CO. KGAA (DE) | 2011-10-13 | — | — | US | claimed |
| EP-2358343-A2 | METHOD FOR DECOLOURING KERATINOUS FIBRES | Henkel AG & Co. KGaA (DE) | 2011-08-24 | — | — | EP | claimed |
| EP-1300132-A2 | Agent for dyeing keratinous fibres | Henkel Kommanditgesellschaft auf Aktien (DE) | 2003-04-09 | — | — | EP | claimed |
| EP-1300133-A2 | Agent for dyeing keratinous fibres | Henkel Kommanditgesellschaft auf Aktien (DE) | 2003-04-09 | — | — | EP | claimed |
| EP-0743574-B1 | Migration imaging members | XEROX CORP (US) | 2000-12-27 | — | — | EP | claimed |
| EP-0743573-B1 | Method for obtaining image contrast migration imaging members | XEROX CORP (US) | 2000-09-06 | — | — | EP | claimed |
| WO-2000038634-A1 | AGENT FOR DYING KERATIN FIBERS | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) | 2000-07-06 | — | — | WO | claimed |
| US-5663029-A | DEVELOPMENT OF LATENT IMAGE, TRANSFERRING TO FORM RECORDING SHEETS, COATING A SUBSTRATE USING POLYMERS | XEROX CORPORATION (US) | 1997-09-02 | — | — | US | claimed |
| EP-0743574-A2 | Migration imaging members | XEROX CORPORATION (US) | 1996-11-20 | — | — | EP | claimed |
| EP-0743573-A2 | Method for obtaining image contrast migration imaging members | XEROX CORPORATION (US) | 1996-11-20 | — | — | EP | claimed |
| US-5563014-A | SOFTENABLE LAYER CONTAINIG PHOTOSENSITIVE MARKING MATERIAL; TRANSPARENTIZING AGENT | XEROX CORPORATION (US) | 1996-10-08 | — | — | US | claimed |
| US-5514505-A | SELECTIVE TRANSPARENTIZATION OF PHOTOSENSITIVE MIGRATION MARKING PARTICLES EMBEDDED NEAR THE SURFACE OF A SOFTENABLE LAYER SUPPORTED BY AN ELECTROCONDUCTIVE SUBSTRATE | XEROX CORPORATION (US) | 1996-05-07 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110247644-A1 | Method for Decolorizing Keratin-Containing Fibers | KRT18, PLOD3, DSG1 | MAPT 125/4885MEN1 4660/4885KMT2A 228/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.